Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

The microbe Pyrodictium abyssi is an archaeon—a member of what's known as the third domain of life—and an extremophile. It ...

Fluorogenic DNA aptamers produce light only in the correct structural state, enabling programmable molecular logic, ...

Dr Ryan Magee graduates today with a PhD in Biological Sciences, having developed a faster, cheaper method to track a major ...

I have spent years covering discoveries that nudge our origin story around the edges, but the sequencing of DNA from one of the very last Neanderthals does something different: it rewrites the center ...

Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Two centuries after Ludwig van Beethoven’s death, a few strands of his hair have given scientists their clearest view yet of what was happening inside his body. By sequencing DNA from authenticated ...

A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and ...

A small group of BYU nursing students traveled to Japan this summer with professor Ryan Rasmussen, graduate program ...

We have long struggled to determine how the first living organisms on Earth came together. Now, surprising evidence hints ...

The standard measure of lesion count may matter less than the underlying biology driving treatment response in ...